<DOC>
	<DOCNO>NCT00506181</DOCNO>
	<brief_summary>Medical literature deal various perspective probiotic therapy - prevention antibiotic associate diarrhoea , Clostridium difficile , etc . However , publish result provide basis generalize recommendation discouragement probiotic use among various group hospitalize patient . The hypothesis benefit probiotic therapy admit patient far large actual cost therapy . This assumption probably true admitted patient patient antibiotic therapy particular .</brief_summary>
	<brief_title>Probiotics : Really That Good ? Cost-Effectiveness Treating in-Patient</brief_title>
	<detailed_description>Probiotics know food supplement available worldwide OTC drug , minimal side effect . Probiotics also recommend food supplement patient suffer antibiotic side effect suffer IBD IBS . All patient admit Internal Medicine Medical Intensive Care Unit randomly divide double blind fashion two group . Group One provide probiotic mixture - one capsule , two time per day . Group Two receive placebo . Group Three receive therapy . Objective parameter duration hospital stay , mortality diarrhea frequency record . In addition , frequency CDT well blood urine culture examine . Furthermore , subjective measure examine use questionnaire fill patient and/or his/her family member , treat nurse . Later data process analyze compare study participant subgroup study ( i.e . patient specific antibiotic therapy ) . For patient , experiment last throughout his/her entire hospital stay . The study last one year 120 patient participate .</detailed_description>
	<mesh_term>Diarrhea</mesh_term>
	<criteria>All patient hospitalize Department Internal Medicine minimum duration 3 day . Age ( &gt; 18 ) gender impact usage drug . patient agree participate study patient NPO ( nothing per o ) order , NPO include medication patient suffer Celiac disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2007</verification_date>
</DOC>